trending Market Intelligence /marketintelligence/en/news-insights/trending/QmrT4uTj7kM2w5aQOP957A2 content esgSubNav
In This List

Zafgen appoints CEO

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Zafgen appoints CEO

Zafgen Inc. named Jeffrey Hatfield as its CEO, replacing Thomas Hughes, who will remain with the company as president and assume the newly created role of chief scientific officer.

Hatfield was most recently the CEO of Vitae Pharmaceuticals.

Both executives will also join the Zafgen board.